Neoadjuvant Cytoreductive Treatment of Regionally Advanced...

Clinical Skin Cancer 2016 / 01 Vol. 1; Iss. 1

Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial

Madu, Max F., Rozeman, E.A. Lisette, van der Hage, Jos A., Wouters, Michel W.J.M., Klop, W. Martin C., van Thienen, J.V. Hans, Blank, Christian U., Haanen, John B.A.G., van Akkooi, Alexander C.J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Language:
english
Journal:
Clinical Skin Cancer
DOI:
10.1016/j.clsc.2016.11.006
Date:
January, 2016
File:
PDF, 582 KB
english, 2016
Conversion to is in progress
Conversion to is failed